Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal
Clinical trial NCT02260037 · COMPLETED
Trial details
- NCT number
- NCT02260037
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2001-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.